EDN1 and metastatic prostate carcinoma: ET-1 was also shown to regulate osteoclast motility and bone resorption in a concentration-dependent manner.2,19,96 Thus, in primarily osteoblastic cancers, such as metastatic prostate cancer,90 ET-1 may negatively regulate osteoclast function while directly contributing to cancer-induced nociceptor sensitization.